Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASTLE: Ultrasound and Elastography for Lymphedema
NCT05613946Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sulfur hexafluoride and perflutren lipid microspheres in lymphedema, sponsored by Mayo Clinic. Started Dec 2022; status: completed.
02
Drugs
sulfur hexafluorideperflutren lipid microspheres
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT05613946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05613946.